25 Years in the Making - Treatment in Schleroderma? Dr. Darren Kelly, CEO, Certa Therapeutics

episode

BioTech Nation ... with Dr. Moira Gunn not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Transrapid, Flugtaxis, Hyperloop – Warum es neuartige Verkehrstechnik so schwer hat 28 min · 22 Sep 2026 · Das Wissen | SWR

AEE 2691: 3 Tips to Master Past Subjunctive Grammar 15 min · 22 Sep 2026 · All Ears English Podcast

RAW Reaction: 946 Kidnaps Solo Sikoa 25 min · 22 Sep 2026 · Busted Open

Auseinandernehmen erlaubt: Traumjob oder Wollmilchsau bei n8n? (279) 45 min · 22 Sep 2026 · PreSales Unleashed | Sales Engineering im B2B Software Vertrieb

Puppets, Pastors & Secret Agents: The Moth Radio Hour 50 min · 22 Sep 2026 · The Moth

US media outlets take legal action after White House ban 29 min · 22 Sep 2026 · Global News Podcast

Report any issue

Source

Recorded19 Apr 2023

Publisherfeeds.transistor.fm ↗

Handlerec:13349864

Show notes

Dr. Darren Kelly, a professor and researcher at the University of Melbourne and the Founder and CEO of Certa Therapeutics, tells us about their clinical trials addressing the skin condition: schleroderma. Their unprecedented approach and the results of their latest trial are worth noting.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in